- ►annals.org MF Gourley, HA Austin III, D Scott, CH … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Uncertainty exists about the efficacy and toxicity of bolus ... Cited by 289 - Related articles - BL Direct - All 5 versions
- ►thelancet.com DT Boumpas, HA Austin… - The Lancet, 1992 - Elsevier 65 patients (60 female, 5 male; median [range] age 29 [10-48] years) with severe
lupus nephritis were assigned randomly to monthly pulse methylprednisolone for 6
months (25 patients), monthly pulse cyclophosphamide for 6 months (20), or ... Cited by 427 - Related articles - All 5 versions
- ►annals.org [PDF] GG Illei, HA Austin III, M Crane, L Collins, … - Annals of internal medicine, 2001 - Am Coll Physicians Gabor G. Illei, MD; Howard A. Austin III, MD; Marianna Crane, NP; Lee Collins,
MS; Mark F. Gourley, MD; Cheryl H. Yarboro, RN; Ellen M. Vaughan, MSN; Takashi
Kuroiwa, MD; Carol L. Danning, MD; Alfred D. Steinberg, MD; John H. ... Cited by 223 - Related articles - BL Direct - All 4 versions
AD Steinberg, SC Steinberg - Arthritis Care & Research - interscience.wiley.com The purpose of this study was to assess long-term preservation of renal function
in 111 patients with systemic lupus erythematosus and active glomerulonephritis
who participated in a randomized treatment trial. Four different drug ... Cited by 242 - Related articles - All 3 versions
FA Houssiau, C Vasconcelos, D D'Cruz, GD … - Rheumatology, 2002 - medscape.com Houssiau and colleagues [1,2] present a multicenter, prospective clinical trial
(the Euro-Lupus Nephritis Trial [1] ), that randomly assigned 90 systemic lupus
erythematosus (SLE) patients with proliferative glomerulonephritis to a ... Cited by 266 - Related articles - BL Direct - All 7 versions
- ►shouxi.net G Contreras, V Pardo, B Leclercq, O Lenz, E … - New England Journal of Medicine, 2004 - content.nejm.org Methods Fifty-nine patients with lupus nephritis (12 in World Health
Organization class III, 46 in class IV, and 1 in class Vb) received induction
therapy consisting of a maximum of seven monthly boluses of intravenous ... Cited by 406 - Related articles - BL Direct - All 7 versions
HA Austin, JH Klippel, JE Balow, NG Le Riche … - New England Journal of Medicine, 1986 - content.nejm.org We evaluated renal function in 107 patients with active lupus nephritis who
participated in long-term randomized therapeutic trials (median follow-up, seven
years). For patients taking oral prednisone alone, the probability of renal ... Cited by 650 - Related articles - All 3 versions
- ►va.gov [PDF] TM Chan, FK Li, CSO Tang, RWS Wong, GX … - The New England journal of medicine, 2000 - nejm.highwire.org ABSTRACT Background The combination of cyclophospha- mide and prednisolone is
effective for the treatment of severe lupus nephritis but has serious adverse
ef- fects. Whether mycophenolate mofetil can be substi- tuted for ... Cited by 556 - Related articles - BL Direct - All 11 versions
MA Dooley, S Hogan, C Jennette, R Falk, … - Kidney international, 1997 - nature.com Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black
Americans. Intravenous cyclophosphamide is widely used to treat severe lupus
nephritis. Yet interpretation of the literature is limited by the small ... Cited by 164 - Related articles - BL Direct - All 3 versions
VK Bansal, JA Beto - American Journal of Kidney Diseases, 1997 - Elsevier The best therapeutic choice in lupus nephritis remains shrouded in a body of
controversial literature. The purpose of this review was to assess and compare
by meta-analysis the efficacy of therapeutic agents used in the treatment ... Cited by 156 - Related articles - BL Direct - All 10 versions
